tiprankstipranks
Checkpoint Therapeutics Inc (CKPT)
NASDAQ:CKPT
US Market

Checkpoint Therapeutics (CKPT) Income Statement

Compare
1,973 Followers

Checkpoint Therapeutics Income Statement

Last quarter (Q3 2024), Checkpoint Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Checkpoint Therapeutics's net income was $-9.72M. See Checkpoint Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 103.00K$ 192.00K$ 268.00K$ 1.07M$ 1.71M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -52.15M$ -58.33M$ -56.72M$ -23.20M$ -24.71M
Operating Income
$ -52.15M$ -58.33M$ -56.72M$ -23.20M$ -24.85M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -51.85M$ -62.62M$ -56.67M$ -23.08M$ -24.71M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Checkpoint Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis